Development, Implementation and Evaluation of MHealth WhatsApp Messages on Risk Communication on Motivation to Quit Cigarettes in a Cohort of Established Adult Poly Tobacco Users in Lagos State, Nigeria.
- Conditions
- Mental and Behavioural Disorders
- Registration Number
- PACTR202407632045339
- Lead Sponsor
- Self
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 120
Eligibility criteria: To enroll in the program participants must be
-18 years of age or older,
-Have smoked at least 100 cigarettes in their lifetime
-Have smoked =5 cigarette(s) per day in the past 3 months, verified by an exhaled carbon monoxide level of =8 ppm.
- Have their own smartphones.
- Able to use a WhatsApp messaging application installed on a cell phone and be familiar with sending and receiving WhatsApp messages.
- Agree to accept health promotion information and communicate through mobile instant messaging to assist cessation,
- Be able to understand messages written in English.
- They should not already be enrolled in another text service to assist smoking cessation.
- Be able and willing to give informed consent.
Excluded from participation are those that:
- Have mental or cognitive impairment or communication problems
- Currently pregnant, assessed by a urine pregnancy test conducted on all premenopausal biologic females who have not had a hysterectomy, or planning to become pregnant in the next 2 months.
- Screening positive for severe alcohol/marijuana use disorder, evidenced by a score = 6 on the Marijuana Screening Inventory 51 and a score = 20 on the Short Alcohol Dependence Data Questionnaire (SADD).52
-Prior serious adverse reaction to the nicotine patch, defined as any reaction that was life-threatening or required hospitalization.
-Heart attack or chest pain within the past 2 weeks.
-Inability to read a sentence written at a primary 4 grade level.
Inability to provide informed consent, assessed with knowledge questions about the material presented during the informed consent process that individuals must correctly answer before providing informed consent to participate.
- Simultaneous participation in another tobacco cessation study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome: The primary outcome biochemically-verified 7-day point prevalence abstinence at 1-, 3- and 6-months. Participants reporting no smoking” in the past 7 days will be coded as abstinent from cigarettes. At each follow-up assessment, participants reporting 7-day abstinence will have an expired CO and saliva cotinine test taken. Participants with CO < 8 ppm and a salivary cotinine level <11 ng/ml, will be considered confirmed nonsmokers.
- Secondary Outcome Measures
Name Time Method • Reduction of cigarette consumption by 50 % or more (y/n) between baseline each follow-up will be calculated from the number of cigarettes smoked in the past 7 days at each time point. Changes in the average number of cigarettes per day relative to baseline, defined by self-report and repeatedly assessed at 1-, 3- and 6-months.<br>• Tobacco quit attempt (y/n). A Follow-up Smoking Questionnaire will assess the presence and number of 24-hour quit attempts since the last assessment, used to calculate the presence of at least one quit attempt in the assessment period.<br>• Readiness to quit tobacco will be assessed using the Stages of Change Questionnaire,44 categorizing participants into five stage categories at each time point (pre-contemplation, contemplation, preparation, action, and maintenance), and predictive of quit attempts and cessation.45 Outcome will be measured as proportion in action or maintenance stage of change at 1-, 3- and 6-month assessments.<br>